Discover 158 paid clinical trials in Reno, Nevada. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 158
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Reno NV, Walnut Creek CA, Las Vegas NV,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase 3, Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Reno NV, Napa CA, Pasadena CA, Santa Monica CA,
Sponsor: Ambros Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07210515
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
for
Carcinoma, Non-Small Cell Lung
Location: Reno NV, Aberdeen WA, Edmonton, Lincoln NE, Leawood KS,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06868277
Phase 3, Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Reno NV, Fresno CA, Salinas CA, Las Vegas NV,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Reno NV, Roseville CA, Greenbrae CA, Clovis CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for
Breast Neoplasms
Location: Reno NV, Los Angeles CA, Newport Beach CA, Tacoma WA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07060807
Phase 3, Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for
Non-small Cell Lung Cancer
Location: Reno NV, Roseville CA, Fresno CA, San Francisco CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07195695
Phase 3, Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Reno NV, San Francisco CA, Las Vegas NV, Eugene OR,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase 3, Recruiting
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
for
Multiple Myeloma
Location: Reno NV, West Hollywood CA, Los Angeles CA, Whittier CA,
Sponsor: Stichting European Myeloma Network
Sex: All
Age: 18+
Code: NCT05028348
Phase 3, Recruiting
New
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
for
Endometrial Neoplasms, Endometrial Cancer
Location: Reno NV, Happy Valley OR, Tigard OR, Portland OR,
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT07578649
Phase 3, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Reno NV, Eugene OR, Phoenix AZ, Tucson AZ, Lone Tree CO,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase 2, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Reno NV, Walnut Creek CA, Portland OR, La Jolla CA,